DeLLphi-306 trial: a phase 3 study of tarlatamab after concurrent chemoradiotherapy in limited-stage small cell lung cancer
Authors
Dowlati, A.Hummel, H. D.
Paz-Ares, L.
Blackhall, Fiona
Chiang, A.
Goldman, J.
Izumi, H.
Mok, T.
Sands, J.
Martinez, P.
Anderson, E. S.
Hamidi, A.
Yu, B.
Yu, Y.
Provencio, M.
Affiliation
Christie NHS Foundation Trust and University of Manchester, Manchester, UKIssue Date
2024